Ligands and receptors of the interleukin-1 family in immunity and disease

Frontiers in Immunology

Volumn 4, Issue NOV, 2013, Pages

  Garlanda, Cecilia ^a   Mantovani, Alberto ^a,b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Adaptive immunity; Autoinflammatory diseases; Decoy receptor; Inflammation; Innate immunity; Interleukin 1

Indexed keywords

EID: 84890400501     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00396     Document Type: Editorial

References (15)

1. Dinarello CA. Anti-inflammatory agents: present and future. Cell (2010) 140:935-50. doi:10.1016/j.cell.2010.02.043
2. O'Neill LA. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal? Trends Immunol (2002) 23:296-300. doi:10.1016/S1471-4906(02)02222-6
3. Muzio M, Ni J, Feng P, Dixit VM. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science (1997) 278:1612-5. doi:10.1126/science.278.5343.1612
4. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 2:253-8. doi:10.1016/S1097-2765(00)80136-7
5. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med (1998) 187:2097-101. doi:10.1084/jem.187.12.2097
6. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (1993) 261:472-5. doi:10.1126/science.8332913
7. Mantovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol (2001) 22:328-36. doi:10.1016/S1471-4906(01)01941-X
8. van de Veerdonk FL, Netea MG. New insights in the immunobiology of IL-1 family members. Front Immunol (2013) 4:167. doi:10.3389/fimmu.2013.00167
9. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol (2013) 4:289. doi:10.3389/fimmu.2013.00289
10. Carta S, Lavieri R, Rubartelli A. Different members of the IL-1 family come out in different ways: DAMPs vs. cytokines? Front Immunol (2013) 4:123. doi:10.3389/fimmu.2013.00123
11. Garlanda C, Riva F, Bonavita E, Gentile S, Mantovani A. Decoys and regulatory "receptors" of the IL-1/toll-like receptor superfamily. Front Immunol (2013) 4:180. doi:10.3389/fimmu.2013.00180
12. Voronov E, Dotan S, Krelin Y, Song X, Elkabets M, Carmi Y, et al. Unique versus redundant functions of IL-1alpha and IL-1beta in the tumor microenvironment. Front Immunol (2013) 4:177. doi:10.3389/fimmu.2013.00177
13. Lopetuso LR, Chowdhry S, Pizarro TT. Opposing functions of classic and novel IL-1 family members in gut health and disease. Front Immunol (2013) 4:181. doi:10.3389/fimmu.2013.00181
14. Federici S, Martini A, Gattorno M. The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol (2013) 4:351. doi:10.3389/fimmu.2013.00351
15. Santarlasci V, Cosmi L, Maggi L, Liotta F, Annunziato F. IL-1 and T helper immune responses. Front Immunol (2013) 4:182. doi:10.3389/fimmu.2013.00182